NEW YORK, Oct 24 – Affymetrix said Tuesday that it broke even in the third quarter, beating Wall Street’s expectations by 12 cents a share.

The company reported net earnings of $295,000, or zero cents a share on a diluted basis, compared with a net loss of $5.8 million, or 11 cents a share, for the same quarter a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.